ArticleAnnals of gastroenterological surgery2026

Unexpectedly High Incidence of Immune-Related Adverse Events in Gastric Cancer Patients Who Received Conversion Surgery After Nivolumab-Including Chemotherapy.

Masashi Nishino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.